FDA Inspection 1169317 — Nemaura Pharma Limited
The FDA completed an inspection of Nemaura Pharma Limited on Apr 21, 2022 in Loughborough. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 21, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Loughborough (United Kingdom)